MedTrace Logo

Prospective Post-market Clinical Follow-up Study of the HBS 2 Resorb Mg in Patients With Intra- and Extraarticular Fractures, Pseudarthroses and Arthrodesis of Small Bones and Bone Fragments.

NCT05483387 · Status: RECRUITING · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2023-03-08

No results posted yet for this study

Summary

This study is a multi-centre, prospective, clinical observational study to evaluate the CE-marked HBS 2 Resorb Mg screws under routine conditions. The device will be used according to its intended use. The data collected for this study does only include measurements which are standard of care.

Conditions

  • Intraarticular Fracture
  • Extraarticular Fracture
  • Pseudarthrosis
  • Arthrosis

Interventions

DEVICE

Treatment with HBS 2 Resorb Mg

Treatment of fractures, arthrodesis or pseudarthroses of small bones and bone fragments

Sponsors & Collaborators

  • Clinical Study Centers, LLC

    collaborator OTHER

  • KLS Martin

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-11-01
Primary Completion
2025-12-31
Completion
2026-01-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05483387 on ClinicalTrials.gov